Premium
SeQuent Scientific Ltd said Tuesday it has entered into a definitive agreement to acquire the 40% stake it doesn’t already own in Turkey-based veterinary products firm Provet. SeQuent will pay $17.10 million (Rs 125.5 crore) in cash to buy the stake from Provet chairman and founder Huseyin Aydin, it said in ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
